Lv5
830 积分 2025-03-08 加入
Sutureless robotic-assisted partial nephrectomy: a propensity score-matched analysis (UroCCR N.158)
2个月前
已完结
Phase II trial of anti PD-1 monoclonal antibody and FOLFOXIRI combined with long-course radiotherapy as the total neoadjuvant treatment for proficient mismatch repair, locally advanced, low rectal cancer (PANFORTE)
4个月前
已完结
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
4个月前
已完结
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers
5个月前
已完结
Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)
5个月前
已关闭
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers
5个月前
已完结
Rethinking endpoints for the watch-and-wait strategy in rectal cancer
5个月前
已完结
Neoadjuvant Chemotherapy vs Upfront Surgery in Patients With Locally Advanced Colon Cancer
5个月前
已完结
Locally Ablative Therapies in Oligometastatic Breast Cancer
5个月前
已完结
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers
5个月前
已关闭
皖公网安备34019202002308
